Quick Ratio
Higher than 88% of Healthcare sector peers
Updated 166h ago
Sector Performance
88th percentileRXRX
5.05x
Sector Median
1.31x
Sector Avg
2.65x
Deep Analysis
Recursion Pharmaceuticals has a quick ratio of 5.05x, meaning it holds over $5 in highly liquid assets (cash, marketable securities, receivables) for every $1 of short-term liabilities — a measure of its ability to pay near-term debts without selling inventory.
This is far above the healthcare sector median of 1.46x and places the company in the 86th percentile among peers, indicating exceptional short-term liquidity relative to the industry. No historical trend data is available; the year-over-year change and quarter-over-quarter change are both reported as N/A, so there is no basis to assess whether this high ratio is stable, improving, or deteriorating. The combination of a very high quick-ratio level with no trend information suggests that while liquidity risk is currently low, the lack of directional context means investors cannot evaluate whether this strength is temporary or sustained. This metric supports the overall CAUTIOUS verdict: an extremely high quick ratio can signal inefficient use of cash or excess capital that could otherwise be deployed for growth, which aligns with the cautious view on the stock.
Frequently Asked Questions
What does the Quick Ratio tell investors about RXRX?
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
How is the Quick Ratio calculated?
Quick Ratio is calculated as: (Cash + Receivables) / Current Liabilities.
How does RXRX's Quick Ratio compare to its sector?
RXRX's Quick Ratio of 5.05x compares to a Healthcare sector median of 1.31x, placing it in the 88th percentile.
Who are RXRX's closest peers by Quick Ratio?
The closest Healthcare peers by Quick Ratio include: BIO (1.02x), BAX (1.01x), BSX (1.00x), BMY (0.91x), DGX (0.91x).
The Formula
(Cash + Receivables) / Current Liabilities
Why It Matters
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
Master RXRX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full RXRX research report →RXRX
5.05x
Sector Median
1.31x
Sector Avg
2.65x
How RXRX's Quick Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.